BCAL Diagnostics Limited (BDX.AX)
AUD 0.09
(-2.17%)
AUD 0.09
(-2.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.44 Million AUD | 31.03% |
| 2023 | -7.89 Million AUD | -92.45% |
| 2022 | -4.1 Million AUD | -127.98% |
| 2021 | -1.8 Million AUD | -58.13% |
| 2020 | -1.13 Million AUD | -66.66% |
| 2019 | -683.1 Thousand AUD | 3.01% |
| 2018 | -704.29 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -1.74 Million AUD | 58.49% |
| 2024 Q2 | -4.21 Million AUD | -280.12% |
| 2024 FY | -9.39 Million AUD | -18.99% |
| 2024 Q1 | -1.1 Million AUD | 74.91% |
| 2024 Q4 | -1.74 Million AUD | 0.0% |
| 2023 FY | -7.89 Million AUD | -92.45% |
| 2023 Q4 | -4.41 Million AUD | -280.3% |
| 2023 Q3 | -1.16 Million AUD | 66.59% |
| 2023 Q2 | -3.47 Million AUD | -192.36% |
| 2023 Q1 | -1.18 Million AUD | 49.54% |
| 2022 Q3 | -989.19 Thousand AUD | 42.67% |
| 2022 FY | -4.1 Million AUD | -127.98% |
| 2022 Q2 | -1.72 Million AUD | -222.62% |
| 2022 Q1 | -534.85 Thousand AUD | 63.87% |
| 2022 Q4 | -2.35 Million AUD | -138.37% |
| 2021 Q4 | -1.48 Million AUD | -329.59% |
| 2021 FY | -1.8 Million AUD | -58.13% |
| 2021 Q1 | -122.34 Thousand AUD | 80.92% |
| 2021 Q2 | -319.77 Thousand AUD | -161.37% |
| 2021 Q3 | -344.61 Thousand AUD | -7.77% |
| 2020 Q3 | -99.76 Thousand AUD | 79.93% |
| 2020 Q1 | -248.41 Thousand AUD | 0.0% |
| 2020 Q4 | -641.32 Thousand AUD | -542.85% |
| 2020 Q2 | -497.14 Thousand AUD | -100.12% |
| 2020 FY | -1.13 Million AUD | -66.66% |
| 2019 FY | -683.1 Thousand AUD | 3.01% |
| 2018 FY | -704.29 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 56.9 Million AUD | 109.572% |
| Genetic Signatures Limited | -22.33 Million AUD | 75.609% |
| Genetic Technologies Limited | -6.53 Million AUD | 16.674% |
| Healius Limited | 39.7 Million AUD | 113.721% |
| Imagion Biosystems Limited | -15.81 Million AUD | 65.555% |
| Integral Diagnostics Limited | 5.36 Million AUD | 201.494% |
| INOVIQ Ltd | -9.51 Million AUD | 42.725% |
| Microba Life Sciences Limited | -26.84 Million AUD | 79.707% |
| Monash IVF Group Limited | -5.34 Million AUD | -1.931% |
| Rhythm Biosciences Limited | -6.7 Million AUD | 18.786% |
| Sonic Healthcare Limited | 816.45 Million AUD | 100.667% |